Improved liquid chromatographic method for mitoxantrone quantification in mouse plasma and tissues to study the pharmacokinetics of a liposome entrapped mitoxantrone formulation

被引:32
作者
Johnson, JL [1 ]
Ahmad, A [1 ]
Khan, S [1 ]
Wang, YF [1 ]
Abu-Qare, AW [1 ]
Ayoub, JE [1 ]
Zhang, A [1 ]
Ahmad, I [1 ]
机构
[1] NeoPharm Inc, Res & Dev, Pharmacokinet Safety & Efficacy Dept, Waukegan, IL 60085 USA
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 799卷 / 01期
关键词
pharmacokinetics; mitoxantrone;
D O I
10.1016/j.jchromb.2003.10.034
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid HPLC method for quantification of mitoxantrone in mouse plasma and tissue homogenates in the presence of a liposome entrapped mitoxantrone formulation (LEM-ETU) is described. Sample preparation is achieved by protein precipitation of 100 mul plasma or 200 RI tissue homogenate with an equal volume of methanol containing 0.5 M hydrochloric acid: acetonitrile (90: 10, v/v). Ametantrone is used as the internal standard (i.s.). Mitoxantrone and i.s. are separated on a C18 reversed phase HPLC column, and quantified by their absorbance at 655 nm. In plasma, the standard curve is linear from 5 to 1000 ng/ml, and the precision (%CV) and accuracy (percentage of nominal concentration) are within 10%. In mouse tissue (heart, kidney, liver, lung, and spleen) homogenates (5%, w/v), the standard curve is linear from 25 to 2000 ng/ml, with acceptable precision and accuracy. The method was used to successfully quantify mitoxantrone in mouse plasma and tissue samples to support a pharmacokinetic study of LEM-ETU in mice. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:149 / 155
页数:7
相关论文
共 15 条
[1]   Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity [J].
Adlakha-Hutcheon, G ;
Bally, MB ;
Shew, CR ;
Madden, TD .
NATURE BIOTECHNOLOGY, 1999, 17 (08) :775-779
[2]   DIRECT DETERMINATION OF MITOXANTRONE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY USING AN AUTOMATIC PRECOLUMN-SWITCHING SYSTEM AS SAMPLE CLEANUP PROCEDURE [J].
CATALIN, J ;
PELOUX, AF ;
COLOMA, F ;
PAYET, B ;
LACARELLE, B ;
CANO, JP ;
JUSTLANDI, S .
BIOMEDICAL CHROMATOGRAPHY, 1994, 8 (01) :37-41
[3]   MITOXANTRONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER [J].
FAULDS, D ;
BALFOUR, JA ;
CHRISP, P ;
LANGTRY, HD .
DRUGS, 1991, 41 (03) :400-449
[4]  
Food-and-Drug-Administration Center for Drug Evaluation and Research, 2001, GUID IND BIOAN METH
[5]  
Gokhale PC, 2001, ANTICANCER RES, V21, P3313
[6]   The pharmacokinetics of liposomes in tumor targeting [J].
Harashima, H ;
Kiwada, H .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 40 (1-2) :1-2
[7]   Evaluation of mitoxantrone for the treatment of multiple sclerosis [J].
Jain, KK .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (05) :1139-1149
[8]  
KELFE DL, 2001, SEMIN ONCOL, V28, P2
[9]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF MITOXANTRONE IN PLASMA UTILIZING NON-BONDED SILICA-GEL FOR SOLID-PHASE ISOLATION TO REDUCE ADSORPTIVE LOSSES ON GLASS DURING SAMPLE PREPARATION [J].
LIN, KT ;
RIVARD, GE ;
LECLERC, JM .
JOURNAL OF CHROMATOGRAPHY, 1989, 465 (01) :75-86
[10]   Evaluation of mitoxantrone-loaded albumin microspheres following intraperitoneal administration to rats [J].
Luftensteiner, CP ;
Schwendenwein, I ;
Paul, B ;
Eichler, HG ;
Viernstein, H .
JOURNAL OF CONTROLLED RELEASE, 1999, 57 (01) :35-44